Search by Categories
- Insights
- Rare Disease
- Oncology
- Cell and Gene Therapy
- Medical Devices
- Consulting
- News & Analysis
-
Therapeutic Areas
Our expertise in the industry
Hutchinson Gilford Progeria Syndrome (HGPS) also refers to as progeria, is an extremely rare and fatal genetic disorder that results in premature aging and death. According to NORD, (as of January 2014), approximately 200 cases were reported. Estimates indicate that the prevalence of HGPS is about 1 in 18 million, ...
Find More-Agonist.png "Toll-like Receptors Agonist")
The American Society of Clinical Oncology (ASCO) is one of the largest and most respected conferences in the field of oncology. Held annually, this conference brings together researchers, physicians, and other healthcare professionals from around the world to discuss the latest advances in cancer research, diagnosis, and treatment.
